Newsfeeds - Spark Newswire

1 minute read

Wedbush Initiates Coverage On Tango Therapeutics with Outperform Rating, Announces Price Target of $20

Today, 1:36 PM

Wedbush analyst Robert Driscoll initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Outperform rating and announces Price Target of $20.

1 minute read

Today, 1:36 PM

Guggenheim initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $16.

1 minute read

Today, 1:36 PM

Goldman Sachs analyst Chris Shibutani initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $17.